Job/Unit: O20346
/KAP1
Date: 30-05-12 16:44:57
Pages: 12
Derivatization of an Elusive Key Biomarker of Lipid Peroxidation
(E)-6-Pentyl-1-[3-(trifluoromethyl)phenyl]-5-{[3-(trifluoromethyl)-
phenyl]diazenyl}-1,4,5,6-tetrahydropyridazine (10b): In MeCN,
37.6 mg of a yellow oil (0.080 mmol, 32%). 1H NMR (400 MHz,
(ddd, J = 9.2, 6.0, 1.6 Hz, 1 H), 5.99 (dd, J = 9.6, 3.2 Hz, 1 H),
4.80 (m, 1 H), 1.80–1.70 (m, 1 H), 1.55–1.45 (m, 1 H), 1.40–1.25
(m, 6 H), 0.87 (t, J = 6.8 Hz, 3 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 7.80 (s, 1 H), 7.67 (d, J = 7.6 Hz, 1 H), 7.64 (d, J = CDCl3): δ = 147.1, 137.3, 132.4 (q, J = 32.2 Hz, 2 C), 128.1, 123.7
7.2 Hz, 1 H), 7.50 (t, J = 7.2 Hz, 1 H), 7.44 (s, 1 H), 7.31 (t, J =
7.6 Hz, 1 H), 7.25 (m overlapped, 1 H), 7.05 (d, J = 7.2 Hz, 1 H),
6.90 (br. s, 1 H), 4.55 (br. t, 1 H), 4.46 (m, 1 H), 2.75 (d, J =
18.8 Hz, 1 H), 2.64 (dd, J = 19.4, 4.8 Hz, 1 H), 1.90–1.75 (m, 1 H),
1.70–1.60 (m, 1 H), 1.60–1.45 (m, 2 H), 1.42–1.30 (m, 4 H), 0.90
(t, J = 6.8 Hz, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 151.7,
147.4, 134.9, 131.8 (q, J = 33.0 Hz), 131.5 (q, J = 33.0 Hz), 129.8,
129.6, 127.4 (q, J = 3.2 Hz), 125.3, 124.6 (q, J = 270 Hz), 123.8 (q,
J = 270 Hz), 119.9 (q, J = 4.0 Hz), 116.4, 116.1 (q, J = 3.2 Hz),
110.7 (q, J = 4.0 Hz), 67.5, 54.9, 31.8, 29.6, 25.6, 23.4, 22.7,
14.1 ppm. LRMS (EI): m/z (%) = 470 (20) [M]+·, 451 (6), 297 (55),
225 (60), 213 (40), 145 (100). LRMS (ESI–) = 469.13 [M – H]–.
HRMS (EI): calcd. for C23H24F6N4 [M]+· 470.1905; found
470.1910.
(q, J = 271 Hz, 2 C), 118.0, 113.5 (q, J = 3.5 Hz, 2 C), 113.2 (q, J
= 4.1 Hz), 52.1, 31.8, 31.4, 23.6, 22.7, 14.1 ppm. HRMS (ESI+):
calcd. for C17H19F6N2 [M + H]+ 365.1452; found 365.1461.
1-[3,5-Bis(trifluoromethyl)phenyl]-5-{2-[3,5-bis(trifluoromethyl)-
phenyl]hydrazinyl}-6-pentyl-1,4,5,6-tetrahydropyridazine (9d): In
MeCN, 78 mg of a yellow oil (0.128 mmol, 51 %). 1H NMR
(400 MHz, CDCl3): δ = 7.45 (s, 2 H), 7.25 (s, 1 H), 7.13 (s, 2 H),
7.11 (s, 1 H), 6.88 (s, 1 H), 5.49 (s, 1 H), 4.18 (br. t, 1 H), 3.61 (br.
s, 1 H), 3.44 (m, 1 H), 2.57 (dd, J = 19.2, 5.2 Hz, 1 H), 2.16 (dd, J
= 19.6 Hz, 1 H), 1.70–1.60 (m, 1 H), 1.55–1.40 (m, 1 H), 1.40–1.20
(m, 6 H), 0.85 (t, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
150.2, 147.6, 135.8, 132.5 (q, J = 33.0 Hz, 2 C), 132.4 (q, J =
33.0 Hz, 2 C), 123.7 (q, J = 271 Hz, 2 C), 123.4 (q, J = 271 Hz, 2
C), 112.4 (m, 4 C), 112.1 (m, 2 C), 52.6, 52.1, 31.8, 29.3, 25.7, 24.7,
22.6, 14.0 ppm. HRMS (ESI+): calcd. for C25H25F12N4 [M + H]+
609.1888; found 609.1893.
6-Pentyl-1-[4-(trifluoromethyl)phenyl]-1,6-dihydropyridazine (8c): In
tBuOH, 47.4 mg of a yellow oil (0.160 mmol, 64 %). 1H NMR
(400 MHz, CDCl3): δ = 7.52 (d, J = 8.4 Hz, 2 H), 7.30 (d, J =
8.8 Hz, 2 H), 7.07 (m, 1 H), 6.07 (td, J = 6.4, 1.6 Hz, 1 H), 5.96
(dd, J = 9.2, 3.2 Hz, 1 H), 4.79 (m, 1 H), 1.82–1.72 (m, 1 H), 1.54–
1.45 (m, 1 H), 1.38–1.22 (m, 6 H), 0.87 (t, J = 6.8 Hz, 3 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 148.5, 136.7, 127.5, 126.5 (q, J
= 4.1 Hz, 2 C), 126.4 (q, J = 269 Hz), 122.0 (q, J = 32.2 Hz), 118.0,
113.7 (2 C), 52.0, 31.9, 31.5, 23.6, 22.7, 14.1 ppm. LRMS (EI+):
m/z (%) = 296 (0.5) [M]+·, 277 (5), 251 (2), 225 (100). LRMS (ESI+)
= 297.05 [M + H]+. HRMS (EI): calcd. for C16H19F3N2 296.1502;
found 296.1510.
(E)-1-[3,5-Bis(trifluoromethyl)phenyl]-5-{[3,5-bis(trifluoromethyl)-
phenyl]diazenyl}-6-pentyl-1,4,5,6-tetrahydropyridazine (10d): A yel-
low oil (18 mg, 0.029 mmol) 1H NMR (400 MHz, CDCl3): δ = 7.96
(s, 2 H), 7.91 (s, 1 H), 7.54 (s, 2 H), 7.28 (s, 1 H), 6.98 (m, 1 H),
4.65 (br. t, J = 6.8 Hz, 1 H), 4.57 (m, 1 H), 2.83 (dd, J = 19.2,
4.0 Hz, 1 H), 2.70 (ddd, J = 19.2, 6.0, 1.6 Hz, 1 H), 1.90–1.75 (m,
1 H), 1.75–1.62 (m, 1 H), 1.60–1.48 (m, 2 H), 1.45–1.30 (m, 4 H),
0.91 (t, J = 6.4 Hz, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
151.8, 147.8, 136.4, 132.9 (q, J = 33.1 Hz, 2 C), 132.5 (q, J =
33.1 Hz, 2 C), 124.3, 123.4 (q, J = 270 Hz, 2 C), 123.0 (q, J =
270 Hz, 2 C), 122.8 (2 C), 113.0 (2 C), 112.7, 67.7, 54.6, 31.7, 29.6,
25.6, 23.2, 22.7, 14.0 ppm. LRMS (ESI–): m/z = 605 [M – H]–.
HRMS (EI): calcd. for C25H22F12N4 [M]+· 606.1653; found
606.1559.
6-Pentyl-1-[4-(trifluoromethyl)phenyl]-5-{2-[4-(trifluoromethyl)-
phenyl]hydrazinyl}-1,4,5,6-tetrahydropyridazine (9c): In MeCN,
65 mg of a yellow oil (0.138 mmol, 55%). 1H NMR (400 MHz,
CDCl3): δ = 7.64 (d, J = 8.4 Hz, 2 H), 7.58 (d, J = 8.4 Hz, 2 H),
7.46 (d, J = 9.2 Hz, 2 H), 7.19 (d, J = 8.8 Hz, 2 H), 6.92 (m, 1 H),
4.57 (br. t, 1 H), 4.45 (m, 1 H), 2.74 (d, J = 19.2 Hz, 1 H), 2.65
(dd, J = 18.4, 5.2 Hz, 1 H), 1.90–1.74 (m, 1 H), 1.73–1.64 (m, 1
H), 1.52–1.45 (m, 2 H), 1.42–1.30 (m, 4 H), 0.91 (t, J = 6.8 Hz, 3
H) ppm. 13C NMR (100 MHz, CDCl3): δ = 153.7, 150.0, 135.4,
130.0, 126.5 (m, 4 C), 123.6 (2 C), 112.9, 112.7 (2 C), 111.9 (2 C),
53.4, 51.6, 31.9, 29.4, 25.7, 24.5, 22.7, 14.2 ppm. LRMS (ESI+):
m/z = 473 [M + H]+. HRMS (ESI+): calcd. for C23H27F6N4 [M +
H]+ 473.2140; found 473.2144.
(E)-1-[(E)-4-Ethoxynon-2-enylidene]-2-[4-(trifluoromethyl)phenyl]-
hydrazine (11c): The reaction was run according to the general pro-
cedure in EtOH (2.0 mL) with aldehyde 1 (0.020 g, 0.128 mmol,
1 equiv.), hydrazine 2c (1.1 equiv.), and a solution of TFA (5% in
EtOH, 0.088 mL, 0.3 equiv.) at 50 °C for 5 h. The crude residue
was purified by flash chromatography (petroleum ether/EtOAc, 9:1
to 8:2) to afford ethyl ether 11c (40%) and 1,6-dihydropyridazine
8c (30%).
11c: Yellow oil (17 mg, 0.078 mmol, 40%). 1H NMR (400 MHz,
[D6]DMSO): δ = 10.5 (s, 1 H), 7.61 (d, J = 9.2 Hz, 1 H), 7.47 (d,
J = 8.4 Hz, 2 H), 7.03 (d, J = 8.4 Hz, 2 H), 6.31 (dd, J = 15.6,
9.6 Hz, 1 H), 5.85 (dd, J = 15.6, 7.2 Hz, 1 H), 3.79 (q, J = 6.4 Hz,
1 H), 3.44 (m, 1 H), 3.30 (m overlapped, 1 H), 1.60–1.45 (m, 2 H),
1.44–1.25 (m, 6 H), 1.08 (t, J = 7.2 Hz, 3 H), 0.84 (t, J = 6.8 Hz,
3 H) ppm. 13C NMR (100 MHz, [D6]DMSO): δ = 148.8, 141.5,
138.9, 129.3, 127.1 (q, J = 4.0 Hz, 2C), 125.6 (q, J = 270 Hz), 118.9
(q, J = 31.4 Hz), 112.2 (2C), 79.6, 63.8, 35.7, 31.9, 25.1, 22.7, 16.0,
14.6 ppm. LRMS (EI): m/z (%) = 342 (2) [M]+·, 323 (3), 296 (10),
239 (8), 212 (56), 185 (10), 145 (10), 85 (18), 57 (100). HRMS (EI):
calcd. for C1.8H25F3N2O [M]+· 342.1919; found 342.1923.
(E)-6-Pentyl-1-[4-(trifluoromethyl)phenyl]-5-{[4-(trifluoromethyl)-
phenyl]diazenyl}-1,4,5,6-tetrahydropyridazine (10c): In MeCN,
41 mg of a yellow oil (0.087 mmol, 35%). 1H NMR (400 MHz,
CDCl3): δ = 7.64 (d, J = 8.4 Hz, 2 H), 7.58 (d, J = 8.4 Hz, 2 H),
7.46 (d, J = 9.2 Hz, 2 H), 7.19 (d, J = 8.8 Hz, 2 H), 6.92 (m, 1 H),
4.57 (br. t, 1 H), 4.45 (m, 1 H), 2.74 (d, J = 19.2 Hz, 1 H), 2.65
(dd, J = 18.4, 5.2 Hz, 1 H), 1.90–1.74 (m, 1 H), 1.73–1.64 (m, 1
H), 1.52–1.45 (m, 2 H), 1.42–1.30 (m, 4 H), 0.91 (t, J = 6.8 Hz, 3
H) ppm. 13C NMR (100 MHz, CDCl3): δ = 153.6, 149.3, 135.3,
132.6 (q, J = 32.3 Hz), 126.5 (m, 4 C), 123.9 (q, J = 276 Hz), 125.0
(q, J = 276 Hz), 122.7 (2 C), 121.2 (q, J = 33.0 Hz), 112.9 (2 C),
67.5, 54.7, 31.9, 29.7, 25.6, 23.5, 22.7, 14.2 ppm. LRMS (EI+): m/z
(%) = 470 (3) [M]+·, 451 (15), 397 (26), 297 (100), 295 (25), 225
(25), 213 (15), 145 (36). HRMS (EI): calcd. for C23H24F6N4 [M]+·
470.1905; found 470.1909.
Reactions of (E)-4-Hydroxynon-2-enal (1) with [2,4-Bis(trifluoro-
methyl)phenyl]hydrazine (2e): Reaction followed the general pro-
cedure with aldehyde 1 (0.020 g, 0.128 mmol, 1 equiv.) hydrazine 2e
1-[3,5-Bis(trifluoromethyl)phenyl]-6-pentyl-1,6-dihydropyridazine (2.0 equiv.) in CH3CN (3 mL) with TFA (5% in CH3CN, 0.156 mL,
(8d): In MeCN, 13 mg of a yellow oil (0.036 mmol, 14 %); in
tBuOH, 56 mg (0.15 mmol, 61%). H NMR (400 MHz, CDCl3): δ
0.3 equiv.) and solid MgSO4. The reaction was heated at 70 °C for
5 h. The crude was purified by flash chromatography (petroleum
1
= 7.64 (s, 2 H), 7.36 (s, 1 H), 7.10 (dd, J = 2.8, 1.6 Hz, 1 H), 6.11 ether/EtOAc, 95:5) to afford 1,6-disubstituted product 12e. Further
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
9